Tag: Research

J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decision

Johnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3...

Mosquito-Resistant, Bite Proof Clothing in the Works

Aug. 11, 2021 — There were 200 hungry mosquitoes in the Plexiglas enclosure volunteers agreed to sit in so scientists could test their new...

U.S. Science Labs Getting Towering New Equipment

Aug. 3, 2021 — To reach the summit of two multimillion-dollar pieces of state-of-the-art equipment, scientists climb stairways spiraling around the structures — each...

Long Covid has more than 200 symptoms, study finds

Patients who experience long COVID report more than 200 symptoms across 10 organ systems, according to the largest global study to date of ‘long-haulers’ published...

Opinion: If you want to fix climate change, you need to fix this flaw in conventional economic thought

BRUSSELS, Belgium (Project Syndicate)—Nowhere are the limitations of neoclassical economic thinking—the DNA of economics as it is currently taught and practiced—more apparent than in the...

Flows into equity mutual funds hit 14-month high as D-street rally draws investors

Flows into equity mutual funds soared to a 14-month high in May as the renewed strength in the stock market prompted investors to pump more...

vedanta: Rising interest rates making it difficult for Anil Agarwal to take control of Vedanta

Anil Agarwal supercharged his rise from scrap metals trader to billionaire commodities magnate by embracing bold acquisitions and lots of debt. But that decades-long playbook...

Pharma industry warns against interfering with COVID vaccine shot intervals

U.S. and European pharmaceutical industry organizations on Wednesday urged governments not to extend the delays prescribed by COVID-19 vaccine developers between the first and second...

How treatment and management of MS has changed over the years, and what’s next.

By Benjamin Segal, MD, as told to Kara Mayer Robinson We’ve come a long way in treating MS — it’s been one of the...

World watches as first person receives Pfizer-BioNTech COVID shot

Manufacturing delays mean just 4 million doses of the vaccine candidate being developed by drugmaker AstraZeneca AZN, +0.97% and the University of Oxford will be...

I’m already trying out a COVID vaccine. But can I get another one injected, in case it was a placebo?

A sign calling for participants on the Research Centers of America vaccine study during the Phase 3 COVID-19 trial of the Moderna vaccine in Hollywood,...

When can I get a COVID-19 vaccine? Will the shots be free? Your vaccine questions, answered

Pfizer and Moderna are both developing a messenger ribonucleic acid (mRNA) vaccine, a new kind of vaccine that teaches cells to create proteins that generate...

This is why I volunteered for the Novavax COVID-19 vaccine trial, and am still cheering for the underdog

Novavax, headquartered in Rockville, Md., was the second company to enter into a late-stage trial of a COVID vaccine in the U.K. AFP via Getty...

Older people, Black and Latinx Americans say they would be hesitant about getting a coronavirus vaccine

Some 46% of Americans ages 50 to 80 would rather wait for others to get vaccinated first before doing it themselves, according to a recent...

For first time, desi scientist creates virtual liver | India News

At its very basic, drug research is about two things — the processes which cause a disease and how those can be altered. The answer...

Is upbeat COVID-vaccine news priced into the market?

A growing list of vaccine candidates have rolled out in recent weeks, offering the world a potential exit from a global pandemic nightmare that has...

Dow, S&P 500 surge by at least 3% to records early Monday on coronavirus vaccine report

U.S. stocks soared in early trading Monday, sending major equity benchmarks to record highs after Germany-based BioNTech SE and Pfizer Inc. said their COVID-19 vaccine...

There are four coronavirus vaccines in late-stage studies — here’s how they differ

Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so...

DRDO sets up 8 technology centres for research on futuristic military applications

New Delhi: India’s premier defence research institute DRDO has set up eight advanced technology centres to carry out research on futuristic military applications, the government...

Can a Cheap Pill Cure Gonorrhea? New Test Can Tell

By Steven Reinberg HealthDay Reporter FRIDAY, Aug. 7, 2020 (HealthDay News) — Researchers say a new test can tell which patients with...

In Rush to Publish, Some COVID Studies Not Reliable

By Dennis Thompson HealthDay Reporter MONDAY, July 27, 2020 (HealthDay News) — The COVID-19 pandemic has prompted a massive scientific response to...

AIIMS: AIIMS to soon conduct 1st autopsy to study virus

New Delhi: The All India Institute of Medical Sciences (AIIMS) is set to study how long coronavirus can remain in the body and whether dead...

State borrowings unlikely to cover revenue losses

KOLKATA: State governments can now borrow more but that won’t be enough to cover their revenue losses because most of the additional limit are contingent...

Coronaviurs in USA: US immunologist warns of ‘darkest winter’ if virus rebounds

WASHINGTON: America faces the “darkest winter in modern history” unless leaders act decisively to prevent a rebound of the coronavirus, says a government whistleblower who...

Trials Test Survivors’ Blood as COVID-19 Treatment

“Blood plasma is the liquid part of the blood,” explained Dr. Arturo Casadevall, chair of Hopkins’ department of molecular microbiology and immunology and lead...